鼻癌的放射治疗:2025年更新
Audrey Larnaudie1, Florent Carsuzaa2, Nolwenn Delaby3
1Department of Radiotherapy, centre François-Baclesse, Caen, France.
概括
这项研究概述了法国辐射瘤学指南,用于鼻癌,罕见的头恶性瘤. 它详细介绍了放射治疗的指示,规划和随访,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 放射疗法是一种放射治疗.
- 头部和部癌症 头部和部癌症
背景情况:
- 鼻癌占头部和部恶性瘤的3-5%,包括各种组织学类型.
- 这些罕见的瘤呈现出非特异性症状,并具有异质的预后.
- 像法国罕见头癌专家网络 (Refcor) 这样的专家网络协调护理和多学科瘤委员会.
研究的目的:
- 提供法国辐射瘤学会 (SFRO) 对鼻癌放射治疗的建议的最新概述.
- 为临床医生指导这些罕见瘤的治疗计划,技术,剂量和体积规格.
- 强调在鼻癌的局部区域性放射治疗中仔细划分目标体积的重要性.
主要方法:
- 审查当前法国放射性瘤治疗学会 (SFRO) 的指导方针.
- 纳入专家病理学审查和多学科瘤委员会建议.
- 专注于在鼻癌中进行放射治疗的具体考虑,包括组织学亚型,等级和节点参与.
主要成果:
- 这篇文章详细介绍了在鼻癌中放射治疗指示的最新建议.
- 它涵盖了治疗规划的关键方面,包括目标体积的划分.
- 提供了关于放射治疗技术,剂量和体积规格以及治疗后的随访指导.
结论:
- 放射治疗在治疗鼻癌方面发挥着至关重要的作用.
- 考虑到瘤特征的量身定制的治疗计划对于有效的放射治疗至关重要.
- 遵守最新的SFRO建议可以优化鼻癌患者的治疗结果.
关键词:
癌症 癌症 癌症 癌症剂量 剂量 剂量我们的鼻子是的.这里是Paranasal和Paranasal.放射疗法是一种放射治疗.放射疗法 (Radiotherapy) 是一种放射疗法.建议 建议 建议 建议建议 建议 建议犀利士的表情是如此.这就是SFRO.在Sinon的salon里.鼻腔 鼻腔是一个神经系统.法国放射治疗瘤学学会.目标量 目标量 目标量量目标 量目标 量目标更多相关视频
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
12.1K
07:00Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
Published on: February 28, 2019
6.2K
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
